Earnings · China A-shares
Kexing Biopharm Co., Ltd. Class A (688136) earnings
Kexing Biopharm Co., Ltd. Class A published its Q3 report on 2026-10-29: net profit -76.58% year on year, -335.75% excluding one-off items. Wave Radar's earnings-quality score is 82 of 100 (Sound). The stock moved -20.50% in the 3 trading days after the report.
- Report
- Q3 report
- Published
- 2026-10-29
- Period end
- 2026-09-30
- Net profit YoY
- -76.58%
- Excl. one-offs YoY
- -335.75%
- Net profit QoQ
- -171.03%
- Result
- Bad / loss
- Quality score
- 82
- Quality
- Sound
Stock move after the report
Trading days from the first tradeable session; dividend-adjusted. "vs index" is the excess return over CSI 300 for A-shares.
| After | Return | vs index |
|---|---|---|
| 1 day | -16.72% | — |
| 3 days | -20.50% | — |
| 7 days | -19.56% | — |
| 14 days | -24.03% | — |
Report history
Over the last 8 reports, net profit grew year on year in 6 of them. The stock rose in the 3 trading days after 4 of 8 reports (average +0.89%).
| Report | Published | Net profit | Profit YoY | Excl. one-offs YoY | Revenue YoY | EPS | ROE | 3 days after | 30 days after | 30d vs index |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026 Q3 report | 2026-10-30 | ¥26.06M | -76.58% | — | -20.38% | 0.13 | 1.49% | -20.50% | — | — |
| 2026 interim report | 2026-08-22 | ¥133.94M | +66.71% | — | -13.33% | 0.68 | 7.41% | +10.12% | +9.54% | +16.45% |
| 2026 Q1 report | 2026-04-29 | -¥17.94M | -170.13% | — | -20.66% | -0.09 | -1.03% | -14.42% | -33.38% | -34.33% |
| 2025 annual report | 2026-04-22 | ¥155.57M | +394.17% | +58.37% | +9.03% | 0.79 | 9.26% | -4.62% | -34.63% | -36.22% |
| 2025 Q3 report | 2025-10-30 | ¥111.26M | +547.70% | +190.65% | +10.54% | 0.56 | 6.66% | +6.14% | -14.09% | -9.35% |
| 2025 interim report | 2025-08-23 | ¥80.34M | +576.45% | +110.30% | -7.82% | 0.41 | 4.80% | -1.66% | -11.82% | -16.69% |
| 2025 Q1 report | 2025-04-28 | ¥25.58M | +106.21% | +124.40% | -1.97% | 0.13 | 1.55% | +1.44% | +35.43% | +32.19% |
| 2024 annual report | 2025-04-11 | ¥31.48M | +116.54% | +117.52% | +11.75% | 0.16 | 1.94% | +30.66% | +57.73% | +54.35% |
The last 8 reports. Net profit is attributable to shareholders and year-to-date (a Q3 report covers the first nine months). Moves count trading days from the first tradeable session after publication; "30d vs index" is the excess return over CSI 300.
How to read this
Results are grouped by reported profit growth (great, good, neutral, bad or a loss). For China A-shares the quality score starts at 100 and loses points for gaps a reader can check: operating cash falling short of profit, receivables or inventory outrunning revenue, profit that rests on one-off items or subsidies, heavy goodwill and a qualified audit opinion.
Figures are generated automatically from Wave Radar's published market data and refresh after each market close.